VelaLabs Announces Strategic Partnership with EarlyHealth Group to Support Biological Drugs Development
VelaLabs GmbH, a leading provider of analytical and quality services for biopharmaceutical development, has signed a Mem…
VelaLabs GmbH, a leading provider of analytical and quality services for biopharmaceutical development, has signed a Mem…
Eine ganze Produktionscharge hängt oftmals von einem negativen Sterilitätsergebnis (no growth) ab und es kann bei Ausfal…
An entire production batch often depends on a negative sterility result (no growth) and if this batch fails, it can lead…
VelaLabs stattet seine Einrichtungen mit einem modernen aseptischen Isolators von Block® für Sterilitätstests aus. Dies…
VelaLabs is soon to be a proud owner of a state-of-the-art aseptic isolator from Block®, used for sterility testing. Thi…
Times are changing and so are we – VelaLabs has grown up and is now moving into the next evolving step of the organizati…
VelaLabs announces that it has successfully been granted the extension of its GLP certification for another 3 years. A…
As an analytical partner biotech and pharma companies, VelaLabs delivers laboratory analysis services and its expertise…
Am 10 Dezember 2020 wurde BIOTECH AUSTRIA als erste Interessensvertretung der Biotechnologie Industrie Österreichs gegr…
Last year in June, VelaLabs, part of the Tentamus Pharma division, acquired the pharmaceutical test laboratory “Laborato…